Dexcom's landmark CONNECT trial, now published in the NEJM, could drive a pivotal CMS coverage decision for type 2 diabetes patients this year.

Resmed CMO Carlos Nunez discusses the Oura and Eight Sleep partnerships, consumer data opt-in trends, and the company's long-term sleep health strategy.

Expanding medical devices into global markets requires manufacturers to navigate diverse regulatory frameworks, testing requirements, quality management expectations, and country-specific approval ...

Make no mistake about it, history was made in Florida on Oct. 25, and the surgical team’s excitement is well earned. Next comes the hard part — getting regulatory, reimbursement, and hospital ...

Dyconex created a biocompatible PCB platform that shrinks medical device interconnects while boosting functionality and ...

Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...

Stryker lowered its 2026 sales and EPS guidance after a Q3 miss, citing slowing joint replacement demand and ...

Senseonics has begun human testing of Freedom, a CGM designed to eliminate the on-body transmitter, with COO Mukul Jain ...

Distalmotion CEO Greg Roche discusses DEXTER's ASC-first design, the company's $70M Perceptive Advisors financing, and ...

Watson Marlow Fluid Technology Solutions spoke with MD+DI about a booth exhibit during MD&M Midwest. The company is a ...

Advances in precious metal materials and alloys optimize strength, radiopacity, and manufacturability for smaller, more ...

The proposed deal follows closely behind Labcorp announcing a deal to acquire certain laboratory testing businesses from ...